X @The Economist
The Economist·2026-03-05 18:10
A more radical split of the drugs and crop-science businesses in Bayer, a pharmaceutical giant, would create the pure plays that investors favour https://t.co/iolnj0mm4f ...
A more radical split of the drugs and crop-science businesses in Bayer, a pharmaceutical giant, would create the pure plays that investors favour https://t.co/iolnj0mm4f ...